Biotech Delivers a Superior Patient and Site Experience with the Medidata Clinical Cloud
Downloadable Case Study
Biotech Delivers a Superior Patient and Site Experience with the Medidata Clinical Cloud
Patient recruitment and retention is a challenge in clinical research—especially in ultra-rare orphan diseases with a limited number of patients and several competing trials.
Download this case study to see how Rezolute, a small biotech company, became a sponsor of choice for patients and sites with the Medidata Clinical Cloud by:
- Reducing study startup time
- Improving study compliance
- Delivering a superior patient and site experience
- Streamlining communication between all trial stakeholders
- Allowing Rezolute to focus on core tasks rather than managing multiple vendors
About Rezolute
Rezolute is a small biotech company advancing targeted therapies for rare, metabolic, and life-threatening diseases. Its lead clinical asset, RZ358, is in Phase 2b development as a potential treatment for congenital hyperinsulinism (CHI), an ultra-rare pediatric endocrine disorder.